Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners

These medtech stocks performed the best in 2020

January 15, 2021 By Sean Whooley

Edwards Sapien 3 Ultra TAVR

Edwards Lifesciences’ Sapien 3 Ultra TAVR [Image courtesy of Edwards Lifesciences]

Edwards Lifesciences

Share price on Dec. 31, 2019: $73.29

Share price on Dec. 31, 2020: $91.23

Change: +24%

 

Edwards Lifesciences (NYSE:EW), a major player in the transcatheter aortic valve replacement (TAVR) space, perhaps got its biggest boost last year with a decision made outside of its own control.

Boston Scientific in November threw in the towel on its Lotus TAVR device, leaving Edwards and its Sapien 3 TAVR device to battle in the space with Medtronic’s Evolut platform. Just one month before Boston Scientific’s decision, the two companies had even launched a head-to-head study to compare the systems.

Still, Edwards had to produce on its own end and, amid a pandemic, continued to put forth strong, Street-beating financial results while producing innovation, too. A big boost came when the company capped off the year by projecting 2021 TAVR sales to represent growth of between 15% and 20% as well as growth in the mid-teens for global sales and a projected adjusted earnings per share for 2021 of between $2 and $2.20.

The company anticipates that its global TAVR opportunity will reach more than $7 billion by 2024, with continued growth to follow.

Outside of TAVR, Edwards is plugging along across multiple other spaces. Corporate VP and the GM of critical care Katie Szyman spoke to Medical Design & Outsourcing in the fall to highlight the company’s commitment to a patient-focused outlook and AI-based critical care options down the line.

Additionally, Edwards made headway in the regulatory processes for a number of devices, including:

  • Treating the first patient in a clinical trial for its Harpoon valve repair system.
  • FDA approval for the Konect Resilia aortic valved conduit (AVC).
  • CE Mark approval for its Pascal transcatheter valve repair system for treating tricuspid regurgitation (TR).

With an optimistic outlook for TAVR and a growing presence across other spaces, Edwards will look to carry on the momentum with which it finished 2020 in 2021.

Next>>

Pages: 1 2 3 4 5 6 7 8 9 10 11

Related Articles Read More >

Pfizer BioNTech vaccine
Pfizer wins FDA nod to store COVID vaccine at normal freezer temps
Hoffer Plastics gains MedAccred certification again
UK passes post-Brexit medical device regulation
Integrated Polymer Solutions acquires IRP Group

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Tweets by MedTechDaily

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Medical Tubing + Extrusion
  • MedTech 100
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertising
  • Subscribe to Enewsletter
  • Subscribe to Print Magazine
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our Device Talks Tuesdays Discussion

Copyright © 2021 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Contract Manufacturing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • Suppliers
    • The Big 100
      • Archive – The Big 100 (2018)
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • Leadership
    • Women in Medtech
    • 2020 Winners
    • 2019 Winners